Albemarle (NYSE: ALB) reported Q4 EPS of ($0.53), $0.02 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.34 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.